CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 107 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2019. The put-call ratio across all filers is 3.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $62,000 | -8.8% | 101,986 | +55.4% | 0.00% | – |
Q3 2021 | $68,000 | -38.7% | 65,612 | +7.6% | 0.00% | – |
Q2 2021 | $111,000 | -11.9% | 60,994 | -5.0% | 0.00% | – |
Q1 2021 | $126,000 | +186.4% | 64,217 | +160.7% | 0.00% | – |
Q3 2020 | $44,000 | -85.6% | 24,629 | -32.5% | 0.00% | – |
Q2 2020 | $305,000 | +510.0% | 36,465 | +276.2% | 0.00% | – |
Q1 2020 | $50,000 | – | 9,692 | +8874.1% | 0.00% | – |
Q4 2019 | $0 | -100.0% | 108 | -99.7% | 0.00% | – |
Q3 2019 | $179,000 | -64.1% | 36,705 | -49.0% | 0.00% | – |
Q2 2019 | $499,000 | +13.4% | 71,995 | +13.7% | 0.00% | – |
Q1 2019 | $440,000 | +746.2% | 63,306 | +600.2% | 0.00% | – |
Q4 2018 | $52,000 | +5100.0% | 9,041 | +5967.8% | 0.00% | – |
Q3 2018 | $1,000 | -98.1% | 149 | -98.6% | 0.00% | – |
Q2 2018 | $54,000 | -68.6% | 10,899 | -61.5% | 0.00% | – |
Q1 2018 | $172,000 | +186.7% | 28,302 | +237.5% | 0.00% | – |
Q4 2017 | $60,000 | -70.0% | 8,385 | -70.1% | 0.00% | – |
Q3 2017 | $200,000 | +163.2% | 28,001 | +132.7% | 0.00% | – |
Q2 2017 | $76,000 | -78.0% | 12,031 | -71.2% | 0.00% | – |
Q1 2017 | $345,000 | -76.5% | 41,777 | -76.0% | 0.00% | -100.0% |
Q4 2016 | $1,470,000 | – | 173,987 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 3,738,925 | $23,555,000 | 31.22% |
Perceptive Advisors | 1,232,500 | $7,764,000 | 0.39% |
IFP Advisors, Inc | 1,001,025 | $6,306,000 | 0.27% |
WOODSTOCK CORP | 55,489 | $350,000 | 0.07% |
Virtus ETF Advisers LLC | 50,795 | $320,000 | 0.05% |
Dynamic Technology Lab Private Ltd | 31,431 | $198,000 | 0.04% |
Evanson Asset Management, LLC | 20,660 | $130,000 | 0.03% |
Artal Group S.A. | 250,000 | $1,575,000 | 0.03% |
GSA CAPITAL PARTNERS LLP | 58,800 | $370,000 | 0.02% |
Raymond James Financial Services Advisors, Inc. | 426,280 | $2,686,000 | 0.02% |